Catherine A Blish, MD/PhD - Publications

Affiliations: 
Infectious Disease Stanford University Medical School 
Area:
Immunology, NK cells, infectious disease

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Wu TT, Travaglini KJ, Rustagi A, Xu D, Zhang Y, Andronov L, Jang S, Gillich A, Dehghannasiri R, Martínez-Colón GJ, Beck A, Liu DD, Wilk AJ, Morri M, Trope WL, ... ... Blish CA, et al. Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung. The Journal of Experimental Medicine. 221. PMID 38597954 DOI: 10.1084/jem.20232192  0.329
2024 Wilk AJ, Marceau JO, Kazer SW, Fleming I, Miao VN, Galvez-Reyes J, Kimata JT, Shalek AK, Holmes S, Overbaugh J, Blish CA. Pro-inflammatory feedback loops define immune responses to pathogenic Lentivirus infection. Genome Medicine. 16: 24. PMID 38317183 DOI: 10.1186/s13073-024-01290-y  0.551
2024 Ratnasiri K, Zheng H, Toh J, Yao Z, Duran V, Donato M, Roederer M, Kamath M, Todd JM, Gagne M, Foulds KE, Francica JR, Corbett KS, Douek DC, Seder RA, ... ... Blish CA, et al. Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans. Cell Reports. 43: 113706. PMID 38294906 DOI: 10.1016/j.celrep.2024.113706  0.563
2023 Lee MJ, Blish CA. Defining the role of natural killer cells in COVID-19. Nature Immunology. PMID 37460639 DOI: 10.1038/s41590-023-01560-8  0.85
2023 Dzanibe S, Wilk AJ, Canny S, Ranganath T, Alinde B, Rubelt F, Huang H, Davis MM, Holmes S, Jaspan HB, Blish CA, Gray CM. Disrupted memory T cell expansion in HIV-exposed uninfected infants is preceded by premature skewing of T cell receptor clonality. Biorxiv : the Preprint Server For Biology. PMID 37292866 DOI: 10.1101/2023.05.19.540713  0.807
2023 Kuo C, Choi S, van Unen V, Zhang H, Rustagi A, Alwahabi S, Santos A, Chan J, Lam B, Solis D, Mah J, Röltgen K, Trope W, Guh-Siesel A, Lin Z, ... ... Blish C, et al. Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection. Research Square. PMID 37205380 DOI: 10.21203/rs.3.rs-2870695/v1  0.458
2023 Wilk AJ, Shalek AK, Holmes S, Blish CA. Comparative analysis of cell-cell communication at single-cell resolution. Nature Biotechnology. PMID 37169965 DOI: 10.1038/s41587-023-01782-z  0.803
2023 Ty M, Sun S, Callaway PC, Rek J, Press KD, van der Ploeg K, Nideffer J, Hu Z, Klemm S, Greenleaf W, Donato M, Tukwasibwe S, Arinaitwe E, Nankya F, Musinguzi K, ... ... Blish C, et al. Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria. Science Translational Medicine. 15: eadd9012. PMID 36696483 DOI: 10.1126/scitranslmed.add9012  0.589
2022 Lee MJ, Leong MW, Rustagi A, Beck A, Zeng L, Holmes S, Qi LS, Blish CA. SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D. Cell Reports. 41: 111892. PMID 36543165 DOI: 10.1016/j.celrep.2022.111892  0.834
2022 Ratnasiri K, Wilk AJ, Lee MJ, Khatri P, Blish CA. Single-cell RNA-seq methods to interrogate virus-host interactions. Seminars in Immunopathology. 1-19. PMID 36414692 DOI: 10.1007/s00281-022-00972-2  0.788
2022 Zhou X, Yu W, Dunham DM, Schuetz JP, Blish CA, DeKruyff RH, Nadeau KC. Cytometric analysis reveals an association between allergen-responsive natural killer cells and human peanut allergy. The Journal of Clinical Investigation. 132. PMID 36250466 DOI: 10.1172/JCI157962  0.382
2022 Hu Z, van der Ploeg K, Chakraborty S, Arunachalam PS, Mori DAM, Jacobson KB, Bonilla H, Parsonnet J, Andrews JR, Holubar M, Subramanian A, Khosla C, Maldonado Y, Hedlin H, de la Parte L, ... ... Blish C, et al. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. Elife. 11. PMID 36239699 DOI: 10.7554/eLife.77943  0.301
2022 Castellano E, Samba C, Esteso G, Simpson L, Vendrame E, García-Cuesta EM, López-Cobo S, Álvarez-Maestro M, Linares A, Leibar A, Ranganath T, Reyburn HT, Martínez-Piñeiro L, Blish C, Valés-Gómez M. CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients. Frontiers in Immunology. 13: 970931. PMID 36189320 DOI: 10.3389/fimmu.2022.970931  0.801
2022 Martínez-Colón GJ, Ratnasiri K, Chen H, Jiang S, Zanley E, Rustagi A, Verma R, Chen H, Andrews JR, Mertz KD, Tzankov A, Azagury D, Boyd J, Nolan GP, Schürch CM, ... ... Blish CA, et al. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Science Translational Medicine. eabm9151. PMID 36137009 DOI: 10.1126/scitranslmed.abm9151  0.793
2022 Richards CM, Jabs S, Qiao W, Varanese LD, Schweizer M, Mosen PR, Riley NM, Klüssendorf M, Zengel JR, Flynn RA, Rustagi A, Widen JC, Peters CE, Ooi YS, Xie X, ... ... Blish CA, et al. The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection. Science (New York, N.Y.). eabn5648. PMID 36074821 DOI: 10.1126/science.abn5648  0.704
2022 Hagey RJ, Elazar M, Pham EA, Tian S, Ben-Avi L, Bernardin-Souibgui C, Yee MF, Moreira FR, Rabinovitch MV, Meganck RM, Fram B, Beck A, Gibson SA, Lam G, Devera J, ... ... Blish CA, et al. Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2. Nature Medicine. PMID 35982307 DOI: 10.1038/s41591-022-01908-x  0.747
2022 Zhu C, Lee JY, Woo JZ, Xu L, Nguyenla X, Yamashiro LH, Ji F, Biering SB, Van Dis E, Gonzalez F, Fox D, Wehri E, Rustagi A, Pinsky BA, Schaletzky J, ... Blish CA, et al. An intranasal ASO therapeutic targeting SARS-CoV-2. Nature Communications. 13: 4503. PMID 35922434 DOI: 10.1038/s41467-022-32216-0  0.731
2022 Biering SB, Sarnik SA, Wang E, Zengel JR, Leist SR, Schäfer A, Sathyan V, Hawkins P, Okuda K, Tau C, Jangid AR, Duffy CV, Wei J, Gilmore RC, Alfajaro MM, ... ... Blish CA, et al. Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection. Nature Genetics. PMID 35879412 DOI: 10.1038/s41588-022-01131-x  0.73
2022 Zeng L, Liu Y, Nguyenla XH, Abbott TR, Han M, Zhu Y, Chemparathy A, Lin X, Chen X, Wang H, Rane DA, Spatz JM, Jain S, Rustagi A, Pinsky B, ... ... Blish CA, et al. Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro. Nature Communications. 13: 2766. PMID 35589813 DOI: 10.1038/s41467-022-30546-7  0.707
2022 Zaslavsky ME, Ram-Mohan N, Guthridge JM, Merrill JT, Goldman JD, Lee JY, Roskin KM, Cunningham-Rundles C, Moody MA, Haynes BF, Pinsky BA, Heath JR, James JA, Yang S, Blish CA, et al. Disease diagnostics using machine learning of immune receptors. Biorxiv : the Preprint Server For Biology. PMID 35547855 DOI: 10.1101/2022.04.26.489314  0.311
2022 Yen M, Ren J, Liu Q, Glassman CR, Sheahan TP, Picton LK, Moreira FR, Rustagi A, Jude KM, Zhao X, Blish CA, Baric RS, Su LL, Garcia KC. Facile discovery of surrogate cytokine agonists. Cell. PMID 35325595 DOI: 10.1016/j.cell.2022.02.025  0.696
2022 Ivison GT, Vendrame E, Martínez-Colón GJ, Ranganath T, Vergara R, Zhao NQ, Martin MP, Bendall SC, Carrington M, Cyktor JC, McMahon DK, Eron J, Jones RB, Mellors JW, Bosch RJ, ... ... Blish CA, et al. Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients. Frontiers in Cellular and Infection Microbiology. 12: 757846. PMID 35223535 DOI: 10.3389/fcimb.2022.757846  0.811
2022 Wilk AJ, Shalek AK, Holmes S, Blish CA. Comparative analysis of cell-cell communication at single-cell resolution. Biorxiv : the Preprint Server For Biology. PMID 35169794 DOI: 10.1101/2022.02.04.479209  0.803
2022 George AF, Luo X, Neidleman J, Hoh R, Vohra P, Thomas R, Shin MG, Lee MJ, Blish CA, Deeks SG, Greene WC, Lee SA, Roan NR. Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART-Suppressed Individuals. Frontiers in Immunology. 13: 803417. PMID 35154118 DOI: 10.3389/fimmu.2022.803417  0.83
2022 Carroll T, Fox D, van Doremalen N, Ball E, Morris MK, Sotomayor-Gonzalez A, Servellita V, Rustagi A, Yinda CK, Fritts L, Port JR, Ma ZM, Holbrook MG, Schulz J, Blish CA, et al. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters. Plos Pathogens. 18: e1009914. PMID 35143587 DOI: 10.1371/journal.ppat.1009914  0.682
2022 Hu Z, van der Ploeg K, Chakraborty S, Arunachalam P, Mori D, Jacobson K, Bonilla H, Parsonnet J, Andrews J, Hedlin H, de la Parte L, Dantzler K, Ty M, Tan G, Blish C, et al. Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19. Research Square. PMID 35132407 DOI: 10.21203/rs.3.rs-847082/v1  0.345
2022 Feng A, Yang E, Moore A, Dhingra S, Chang S, Yin X, Pi R, Mack E, Völkel S, Geßner R, Gundisch M, Neubauer A, Renz H, Tsiodras S, Fragkou P, ... ... Blish C, et al. Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infections. Research Square. PMID 35075455 DOI: 10.21203/rs.3.rs-1233038/v1  0.313
2021 Dzanibe S, Lennard K, Kiravu A, Seabrook MSS, Alinde B, Holmes SP, Blish CA, Jaspan HB, Gray CM. Stereotypic Expansion of T Regulatory and Th17 Cells during Infancy Is Disrupted by HIV Exposure and Gut Epithelial Damage. Journal of Immunology (Baltimore, Md. : 1950). PMID 34819390 DOI: 10.4049/jimmunol.2100503  0.33
2021 Carroll T, Fox D, van Doremalen N, Ball E, Morris MK, Sotomayor-Gonzalez A, Servellita V, Rustagi A, Yinda CK, Fritts L, Port JR, Ma ZM, Holbrook M, Schulz J, Blish CA, et al. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters. Biorxiv : the Preprint Server For Biology. PMID 34462750 DOI: 10.1101/2021.08.25.457626  0.683
2021 Verma R, Kim E, Martínez-Colón GJ, Jagannathan P, Rustagi A, Parsonnet J, Bonilla H, Khosla C, Holubar M, Subramanian A, Singh U, Maldonado Y, Blish CA, Andrews JR. SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples. Open Forum Infectious Diseases. 8: ofab310. PMID 34295944 DOI: 10.1093/ofid/ofab310  0.673
2021 Wilk AJ, Lee MJ, Wei B, Parks B, Pi R, Martínez-Colón GJ, Ranganath T, Zhao NQ, Taylor S, Becker W, Jimenez-Morales D, Blomkalns AL, O'Hara R, Ashley EA, ... ... Blish CA, et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. The Journal of Experimental Medicine. 218. PMID 34128959 DOI: 10.1084/jem.20210582  0.798
2021 Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, Hoffman P, Stoeckius M, Papalexi E, Mimitou EP, Jain J, ... ... Blish CA, et al. Integrated analysis of multimodal single-cell data. Cell. PMID 34062119 DOI: 10.1016/j.cell.2021.04.048  0.808
2021 Delaveris CS, Wilk AJ, Riley NM, Stark JC, Yang SS, Rogers AJ, Ranganath T, Nadeau KC, Blish CA, Bertozzi CR. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. Acs Central Science. 7: 650-657. PMID 34056095 DOI: 10.1021/acscentsci.0c01669  0.8
2021 Seiler C, Ferreira AM, Kronstad LM, Simpson LJ, Le Gars M, Vendrame E, Blish CA, Holmes S. CytoGLMM: conditional differential analysis for flow and mass cytometry experiments. Bmc Bioinformatics. 22: 137. PMID 33752595 DOI: 10.1186/s12859-021-04067-x  0.795
2020 Delaveris C, Wilk A, Riley N, Stark J, Yang S, Rogers A, Ranganath T, Nadeau K, Blish C, Bertozzi C. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. Chemrxiv : the Preprint Server For Chemistry. PMID 33469569 DOI: 10.26434/chemrxiv.13378148.v1  0.801
2020 Röltgen K, Powell AE, Wirz OF, Stevens BA, Hogan CA, Najeeb J, Hunter M, Wang H, Sahoo MK, Huang C, Yamamoto F, Manohar M, Manalac J, Otrelo-Cardoso AR, Pham TD, ... ... Blish CA, et al. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Science Immunology. 5. PMID 33288645 DOI: 10.1126/sciimmunol.abe0240  0.711
2020 Vendrame E, McKechnie JL, Ranganath T, Zhao NQ, Rustagi A, Vergara R, Ivison GT, Kronstad LM, Simpson LJ, Blish CA. Profiling of the Human Natural Killer Cell Receptor-Ligand Repertoire. Journal of Visualized Experiments : Jove. PMID 33283785 DOI: 10.3791/61912  0.787
2020 Salahudeen AA, Choi SS, Rustagi A, Zhu J, van Unen V, de la O SM, Flynn RA, Margalef-Català M, Santos AJM, Ju J, Batish A, Usui T, Zheng GXY, Edwards CE, Wagar LE, ... ... Blish CA, et al. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids. Nature. PMID 33238290 DOI: 10.1038/s41586-020-3014-1  0.711
2020 McKechnie JL, Beltrán D, Ferreira AM, Vergara R, Saenz L, Vergara O, Estripeaut D, Araúz AB, Simpson LJ, Holmes S, López-Vergès S, Blish CA. Mass Cytometry Analysis of the NK Cell Receptor-Ligand Repertoire Reveals Unique Differences between Dengue-Infected Children and Adults. Immunohorizons. 4: 634-647. PMID 33067399 DOI: 10.4049/immunohorizons.2000074  0.832
2020 Nielsen SCA, Yang F, Jackson KJL, Hoh RA, Röltgen K, Jean GH, Stevens BA, Lee JY, Rustagi A, Rogers AJ, Powell AE, Hunter M, Najeeb J, Otrelo-Cardoso AR, Yost KE, ... ... Blish CA, et al. Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2. Cell Host & Microbe. PMID 32941787 DOI: 10.1016/J.Chom.2020.09.002  0.764
2020 Wilk AJ, Weidenbacher NL, Vergara R, Haabeth OAW, Levy R, Waymouth RM, Wender PA, Blish CA. Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy. Blood Advances. 4: 4244-4255. PMID 32898247 DOI: 10.1182/Bloodadvances.2020002355  0.824
2020 Zhao NQ, Vendrame E, Ferreira AM, Seiler C, Ranganath T, Alary M, Labbé AC, Guédou F, Poudrier J, Holmes S, Roger M, Blish CA. Natural killer cell phenotype is altered in HIV-exposed seronegative women. Plos One. 15: e0238347. PMID 32870938 DOI: 10.1371/Journal.Pone.0238347  0.827
2020 Röltgen K, Wirz OF, Stevens BA, Powell AE, Hogan CA, Najeeb J, Hunter M, Sahoo MK, Huang C, Yamamoto F, Manalac J, Otrelo-Cardoso AR, Pham TD, Rustagi A, Rogers AJ, ... ... Blish CA, et al. SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness. Medrxiv : the Preprint Server For Health Sciences. PMID 32839786 DOI: 10.1101/2020.08.15.20175794  0.717
2020 Salahudeen AA, Choi SS, Rustagi A, Zhu J, de la O SM, Flynn RA, Margalef-Català M, Santos AJM, Ju J, Batish A, van Unen V, Usui T, Zheng GXY, Edwards CE, Wagar LE, ... ... Blish CA, et al. Progenitor identification and SARS-CoV-2 infection in long-term human distal lung organoid cultures. Biorxiv : the Preprint Server For Biology. PMID 32743583 DOI: 10.1101/2020.07.27.212076  0.72
2020 Wilson JG, Simpson LJ, Ferreira AM, Rustagi A, Roque JA, Asuni A, Ranganath T, Grant PM, Subramanian AK, Rosenberg-Hasson Y, Maecker H, Holmes S, Levitt JE, Blish C, Rogers AJ. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. Jci Insight. PMID 32706339 DOI: 10.1172/jci.insight.140289  0.774
2020 Nielsen SCA, Yang F, Hoh RA, Jackson KJL, Roeltgen K, Lee JY, Rustagi A, Rogers AJ, Powell AE, Kim PS, Wang TT, Pinsky B, Blish CA, Boyd SD. B cell clonal expansion and convergent antibody responses to SARS-CoV-2. Research Square. PMID 32702737 DOI: 10.21203/rs.3.rs-27220/v1  0.749
2020 Nielsen SCA, Yang F, Jackson KJL, Hoh RA, Röltgen K, Stevens B, Lee JY, Rustagi A, Rogers AJ, Powell AE, Najeeb J, Otrelo-Cardoso AR, Yost KE, Daniel B, Chang HY, ... ... Blish CA, et al. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 32676593 DOI: 10.1101/2020.07.08.194456  0.761
2020 Wilk AJ, Rustagi A, Zhao NQ, Roque J, Martínez-Colón GJ, McKechnie JL, Ivison GT, Ranganath T, Vergara R, Hollis T, Simpson LJ, Grant P, Subramanian A, Rogers AJ, Blish CA. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nature Medicine. PMID 32514174 DOI: 10.1038/s41591-020-0944-y  0.796
2020 Wilk AJ, Rustagi A, Zhao NQ, Roque J, Martinez-Colon GJ, McKechnie JL, Ivison GT, Ranganath T, Vergara R, Hollis T, Simpson LJ, Grant P, Subramanian A, Rogers AJ, Blish CA. A single-cell atlas of the peripheral immune response to severe COVID-19. Medrxiv : the Preprint Server For Health Sciences. PMID 32511639 DOI: 10.1101/2020.04.17.20069930  0.79
2020 Zhao NQ, Ferreira AM, Grant PM, Holmes S, Blish CA. Treated HIV Infection Alters Phenotype but Not HIV-Specific Function of Peripheral Blood Natural Killer Cells. Frontiers in Immunology. 11: 829. PMID 32477342 DOI: 10.3389/Fimmu.2020.00829  0.816
2020 McKechnie JL, Blish CA. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19? Cell Host & Microbe. 27: 863-869. PMID 32464098 DOI: 10.1016/j.chom.2020.05.009  0.803
2020 Ranganath T, Simpson LJ, Ferreira AM, Seiler C, Vendrame E, Zhao N, Fontenot JD, Holmes S, Blish CA. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry. Frontiers in Immunology. 11: 714. PMID 32391016 DOI: 10.3389/Fimmu.2020.00714  0.795
2020 Ramadoss NS, Zhao NQ, Richardson BA, Grant PM, Kim PS, Blish CA. Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection. Aids (London, England). PMID 32287071 DOI: 10.1097/Qad.0000000000002543  0.808
2020 Seiler C, Bayless NL, Vergara R, Pintye J, Kinuthia J, Osborn L, Matemo D, Richardson BA, John-Stewart G, Holmes S, Blish CA. Influenza-Induced Interferon Lambda Response Is Associated With Longer Time to Delivery Among Pregnant Kenyan Women. Frontiers in Immunology. 11: 452. PMID 32256497 DOI: 10.3389/Fimmu.2020.00452  0.781
2020 Vendrame E, Seiler C, Ranganath T, Zhao NQ, Vergara R, Alary M, Labbé AC, Guédou F, Poudrier J, Holmes S, Roger M, Blish CA. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells. Aids (London, England). PMID 32028328 DOI: 10.1097/Qad.0000000000002488  0.815
2020 Portilla AP, Moraru M, Moreno AB, Kolb P, García-Morato MB, Ranganath T, Esteso G, Gianelli C, Rodríguez-Pena R, Rodríguez RL, Torres-Canizales JM, Blish CA, Vales-Gomez M, Hengel H, Vilches C, et al. Identification of the first cases of complete CD16A deficiency: association with persistent EBV infection. The Journal of Allergy and Clinical Immunology. PMID 31953104 DOI: 10.1016/j.jaci.2019.11.049  0.37
2019 Le Gars M, Seiler C, Kay AW, Bayless NL, Starosvetsky E, Moore L, Shen-Orr SS, Aziz N, Khatri P, Dekker CL, Swan GE, Davis MM, Holmes S, Blish CA. Pregnancy-Induced Alterations in NK Cell Phenotype and Function. Frontiers in Immunology. 10: 2469. PMID 31708922 DOI: 10.3389/Fimmu.2019.02469  0.825
2019 McKechnie JL, Beltrán D, Pitti A, Saenz L, Araúz AB, Vergara R, Harris E, Lanier LL, Blish CA, López-Vergès S. HLA Upregulation During Dengue Virus Infection Suppresses the Natural Killer Cell Response. Frontiers in Cellular and Infection Microbiology. 9: 268. PMID 31396492 DOI: 10.3389/Fcimb.2019.00268  0.83
2019 Fernandez IZ, Baxter RM, Garcia-Perez JE, Vendrame E, Ranganath T, Kong DS, Lundquist K, Nguyen T, Ogolla S, Black J, Galambos C, Gumbart JC, Dawany N, Kelsen JR, de Zoeten EF, ... ... Blish CA, et al. Correction: A novel human mutation results in T and NK cell-driven immune dysregulation. The Journal of Experimental Medicine. PMID 31088899 DOI: 10.1084/Jem.2018201505102019C  0.773
2019 Nikzad R, Angelo LS, Aviles-Padilla K, Le DT, Singh VK, Bimler L, Vukmanovic-Stejic M, Vendrame E, Ranganath T, Simpson L, Haigwood NL, Blish CA, Akbar AN, Paust S. Human natural killer cells mediate adaptive immunity to viral antigens. Science Immunology. 4. PMID 31076527 DOI: 10.1126/Sciimmunol.Aat8116  0.829
2019 Fernandez IZ, Baxter RM, Garcia-Perez JE, Vendrame E, Ranganath T, Kong DS, Lundquist K, Nguyen T, Ogolla S, Black J, Galambos C, Gumbart JC, Dawany N, Kelsen JR, de Zoeten EF, ... ... Blish CA, et al. A novel human mutation results in T and NK cell-driven immune dysregulation. The Journal of Experimental Medicine. PMID 31040184 DOI: 10.1084/Jem.20182015  0.745
2018 Kronstad LM, Seiler C, Vergara R, Holmes SP, Blish CA. Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses. Journal of Immunology (Baltimore, Md. : 1950). PMID 30143589 DOI: 10.4049/jimmunol.1800161  0.351
2018 Wilk AJ, Blish CA. Diversification of human NK cells: Lessons from deep profiling. Journal of Leukocyte Biology. 103: 629-641. PMID 29350874 DOI: 10.1002/JLB.6RI0917-390R  0.826
2017 Paust S, Blish CA, Reeves RK. Redefining Memory: Building the Case for Adaptive NK Cells. Journal of Virology. 91. PMID 28794018 DOI: 10.1128/Jvi.00169-17  0.415
2017 Yao Y, Strauss-Albee DM, Zhou JQ, Malawista A, Garcia MN, Murray KO, Blish CA, Montgomery RR. The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection. Plos One. 12: e0172625. PMID 28235099 DOI: 10.1371/Journal.Pone.0172625  0.453
2016 Hatton O, Strauss-Albee DM, Zhao NQ, Haggadone MD, Pelpola JS, Krams SM, Martinez OM, Blish CA. NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus. Frontiers in Immunology. 7: 607. PMID 28018364 DOI: 10.3389/Fimmu.2016.00607  0.84
2016 Vendrame E, Fukuyama J, Strauss-Albee DM, Holmes S, Blish CA. Mass cytometry analytical approaches reveal cytokine-induced changes in natural killer cells. Cytometry. Part B, Clinical Cytometry. PMID 27933717 DOI: 10.1002/Cyto.B.21500  0.811
2016 Bayless NL, Greenberg RS, Swigut T, Wysocka J, Blish CA. Zika Virus Infection Induces Cranial Neural Crest Cells to Produce Cytokines at Levels Detrimental for Neurogenesis. Cell Host & Microbe. 20: 423-428. PMID 27693308 DOI: 10.1016/J.Chom.2016.09.006  0.806
2016 Le Gars M, Kay AW, Bayless NL, Aziz N, Dekker CL, Swan GE, Davis MM, Blish CA. Increased Pro-Inflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy. The Journal of Infectious Diseases. PMID 27655870 DOI: 10.1093/Infdis/Jiw448  0.811
2016 Blish CA. Natural Killer Cell Diversity in Viral Infection: Why and How Much? Pathogens & Immunity. 1: 165-192. PMID 27635417 DOI: 10.20411/pai.v1i1.142  0.431
2016 Strauss-Albee DM, Blish CA. Human NK Cell Diversity in Viral Infection: Ramifications of Ramification. Frontiers in Immunology. 7: 66. PMID 26973646 DOI: 10.3389/fimmu.2016.00066  0.468
2015 Strauss-Albee DM, Fukuyama J, Liang EC, Yao Y, Jarrell JA, Drake AL, Kinuthia J, Montgomery RR, John-Stewart G, Holmes S, Blish CA. Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility. Science Translational Medicine. 7: 297ra115. PMID 26203083 DOI: 10.1126/Scitranslmed.Aac5722  0.431
2015 Grow EJ, Flynn RA, Chavez SL, Bayless NL, Wossidlo M, Wesche DJ, Martin L, Ware CB, Blish CA, Chang HY, Pera RA, Wysocka J. Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells. Nature. 522: 221-5. PMID 25896322 DOI: 10.1038/Nature14308  0.816
2015 Kay AW, Bayless NL, Fukuyama J, Aziz N, Dekker CL, Mackey S, Swan GE, Davis MM, Blish CA. Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine. The Journal of Infectious Diseases. PMID 25740957 DOI: 10.1093/Infdis/Jiv138  0.771
2014 Strauss-Albee DM, Horowitz A, Parham P, Blish CA. Coordinated regulation of nk receptor expression in the maturing human immune system Journal of Immunology. 193: 4871-4879. PMID 25288567 DOI: 10.4049/Jimmunol.1401821  0.377
2014 Liang EC, Sceats L, Bayless NL, Strauss-Albee DM, Kubo J, Grant PM, Furman D, Desai M, Katzenstein DA, Davis MM, Zolopa AR, Blish CA. Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults. Journal of Virology. 88: 8629-39. PMID 24850730 DOI: 10.1128/Jvi.01257-14  0.828
2014 Blish CA, Dogan OC, Jaoko W, McClelland RS, Mandaliya K, Odem-Davis K, Richardson BA, Overbaugh J. Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection. Journal of Virology. 88: 5894-9. PMID 24623424 DOI: 10.1128/JVI.00187-14  0.534
2014 Lehman DA, Ronen K, Blish CA, Baeten JM, Jalalian-Lechak Z, Jaoko W, Mandaliya K, Richardson BA, McClelland RS, Overbaugh J. Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 135-9. PMID 24413043 DOI: 10.1097/Qai.0000000000000104  0.455
2014 Hatton O, Hadad U, Strauss-Albee D, Blish C, Esquivel C, Krams S, Martinez O. Natural Killer Cell Responses to Autologous and Allogeneic Epstein-Barr Virus (EBV)+ B Cell Lymphomas. Transplantation. 98: 245-246. DOI: 10.1097/00007890-201407151-00736  0.321
2013 Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, Dekker CL, Mackey S, Maecker H, Swan GE, Davis MM, Norman PJ, Guethlein LA, Desai M, Parham P, ... Blish CA, et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Science Translational Medicine. 5: 208ra145. PMID 24154599 DOI: 10.1126/Scitranslmed.3006702  0.374
2013 Forthal DN, Landucci G, Chohan B, Richardson BA, McClelland RS, Jaoko W, Blish C, Overbaugh J. Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 31-3. PMID 23344546 DOI: 10.1097/Qai.0B013E3182874D41  0.725
2012 Blish CA, McClelland RS, Richardson BA, Jaoko W, Mandaliya K, Baeten JM, Overbaugh J. Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 436-40. PMID 22878424 DOI: 10.1097/Qai.0B013E31826C2Edd  0.456
2012 Blish CA, Dogan OC, Jaoko W, McClelland RS, Mandaliya K, Odem-Davis KS, Richardsonb BA, Overbaugh J. Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study. Aids (London, England). 26: 643-6. PMID 22210637 DOI: 10.1097/Qad.0B013E3283509A0B  0.535
2011 Lovelace E, Xu H, Blish CA, Strong R, Overbaugh J. The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization. Virology. 421: 235-44. PMID 22029936 DOI: 10.1016/J.Virol.2011.09.032  0.421
2011 Lynch JB, Nduati R, Blish CA, Richardson BA, Mabuka JM, Jalalian-Lechak Z, John-Stewart G, Overbaugh J. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection. Journal of Virology. 85: 5252-61. PMID 21411521 DOI: 10.1128/Jvi.02216-10  0.489
2011 Overbaugh J, Blish C, Lynch J, Provine N, Team tSR. 143 HIV Transmission: The Role of Neutralizing Antibodies Jaids Journal of Acquired Immune Deficiency Syndromes. 56: 58. DOI: 10.1097/01.Qai.0000397329.72363.9C  0.429
2010 Blish CA, Sather DN, Sellhorn G, Stamatatos L, Sun Y, Srivastava I, Barnett SW, Cleveland B, Overbaugh J, Hu SL. Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes. Journal of Virology. 84: 2573-84. PMID 20015987 DOI: 10.1128/Jvi.01687-09  0.493
2009 Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland RS, Overbaugh J. Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression. Journal of Virology. 83: 10269-74. PMID 19640996 DOI: 10.1128/Jvi.01149-09  0.74
2009 Blish CA, Jalalian-Lechak Z, Rainwater S, Nguyen MA, Dogan OC, Overbaugh J. Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1. Journal of Virology. 83: 7783-8. PMID 19474105 DOI: 10.1128/Jvi.00673-09  0.499
2008 Blish CA, Dogan OC, Derby NR, Nguyen MA, Chohan B, Richardson BA, Overbaugh J. Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses. Journal of Virology. 82: 12094-103. PMID 18842728 DOI: 10.1128/Jvi.01730-08  0.735
2008 Blish CA, Nguyen MA, Overbaugh J. Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41. Plos Medicine. 5: e9. PMID 18177204 DOI: 10.1371/Journal.Pmed.0050009  0.455
2007 Blish CA, Blay WM, Haigwood NL, Overbaugh J. Transmission of HIV-1 in the face of neutralizing antibodies. Current Hiv Research. 5: 578-87. PMID 18045114 DOI: 10.2174/157016207782418461  0.504
2007 Blish CA, Nedellec R, Mandaliya K, Mosier DE, Overbaugh J. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry. Aids (London, England). 21: 693-702. PMID 17413690 DOI: 10.1097/Qad.0B013E32805E8727  0.511
Show low-probability matches.